Metrum Research Group, established in 2004, is a global leader in biomedical modeling and simulation. We have provided strategic decision making for more than 100 companies on over 300 projects. At Metrum Research Group we support our clients in advancing drug development programs by supplying them with the highest quality scientific expertise.
With over 100 clients, Metrum Research Group works with companies of all sizes, from venture startups to Fortune 500s. Our role in client drug development programs can range from leading the modeling and simulation strategies to the performance of all related quantitative analyses. We provide our clients with true decision-making results that have a fundamental impact on development programs.
Metrum Research Group has selectively recruited the very best in quantitative modeling and simulation. Every member of our scientific staff has broad experience (averaging over 15 years) in pharmaceutical sciences, statistics, mathematics, and information technology. Our scientists are continually advancing the science and publish extensively. Take a look at our Team and Publications pages for a closer look.
Metrum Research Group utilizes a secure, high-performance, highly managed, distributed computing environment for all of its modeling and simulation analyses. Our workflows are systematically driven by process and yield consistent, repeatable results, all supported by a robust quality assurance program. All of our technologies are the result of significant internal investments, which continue to drive our services to the highest levels.
Metrum Research Group has been recognized for its excellence and leadership in biomedical modeling and simulation through several industry channels. We are listed in the Inc500|5000 and are a three time recipient of the Marcum Tech Top 40 Award in Life Sciences.